| Literature DB >> 26320740 |
Catherine Desrumaux1,2,3, Stéphanie Lemaire-Ewing1,2,3,4, Nicolas Ogier1,2,3, Akadiri Yessoufou1,2,3, Arlette Hammann1,3,4, Anabelle Sequeira-Le Grand2,5, Valérie Deckert1,2,3, Jean-Paul Pais de Barros1,2,3, Naïg Le Guern1,2,3, Julien Guy4, Naim A Khan1,2,3, Laurent Lagrost1,2,3,4.
Abstract
OBJECTIVE: Plasma phospholipid transfer protein (PLTP) is a key determinant of lipoprotein metabolism, and both animal and human studies converge to indicate that PLTP promotes atherogenesis and its thromboembolic complications. Moreover, it has recently been reported that PLTP modulates inflammation and immune responses. Although earlier studies from our group demonstrated that PLTP can modify macrophage activation, the implication of PLTP in the modulation of T-cell-mediated immune responses has never been investigated and was therefore addressed in the present study. Approach and results: In the present study, we demonstrated that PLTP deficiency in mice has a profound effect on CD4+ Th0 cell polarization, with a shift towards the anti-inflammatory Th2 phenotype under both normal and pathological conditions. In a model of contact hypersensitivity, a significantly impaired response to skin sensitization with the hapten-2,4-dinitrofluorobenzene (DNFB) was observed in PLTP-deficient mice compared to wild-type (WT) mice. Interestingly, PLTP deficiency in mice exerted no effect on the counts of total white blood cells, lymphocytes, granulocytes, or monocytes in the peripheral blood. Moreover, PLTP deficiency did not modify the amounts of CD4+ and CD8+ T lymphocyte subsets. However, PLTP-deficiency, associated with upregulation of the Th2 phenotype, was accompanied by a significant decrease in the production of the pro-Th1 cytokine interleukin 18 by accessory cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26320740 PMCID: PMC5101448 DOI: 10.1038/cmi.2015.75
Source DB: PubMed Journal: Cell Mol Immunol ISSN: 1672-7681 Impact factor: 11.530